Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,142
Total Claims
$714K
Drug Cost
591
Beneficiaries
$1,208
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-98%
Opioid rate vs peers
0.1% vs 3.8% avg
+3%
Cost per patient vs peers
$1,208 vs $1,174 avg
-21%
Brand preference vs peers
7.0% vs 8.9% avg
Opioid Prescribing
0.1%
Opioid Rate
20
Opioid Claims
$57
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,523 claims · $486K
Generic: 20,228 claims · $214K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 112 | $62K |
| Insulin Glargine,hum.Rec.Anlog | 135 | $56K |
| Apixaban | 93 | $52K |
| Dulaglutide | 46 | $43K |
| Sacubitril/Valsartan | 52 | $38K |
| Insulin Glargine,hum.Rec.Anlog | 76 | $31K |
| Insulin Detemir | 70 | $24K |
| Sitagliptin Phosphate | 35 | $23K |
| Fluticasone Propion/Salmeterol | 81 | $19K |
| Sitagliptin Phos/Metformin Hcl | 27 | $13K |
| Ezetimibe | 187 | $11K |
| Atorvastatin Calcium | 2,121 | $10K |
| Insulin Glargine,hum.Rec.Anlog | 22 | $10K |
| Levothyroxine Sodium | 718 | $9,917 |
| Fluticasone/Umeclidin/Vilanter | 15 | $9,251 |
Prescribing Profile
Patient Profile
74
Avg Age
62%
Female
2.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data